A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters.

Acta neurologica Scandinavica2003Ryberg H, Askmark H, Persson LI

Study designRandomized controlled trial

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdultAgedAmino Acids, Branched-ChainAmyotrophic Lateral SclerosisAspartic AcidCross-Over StudiesDouble-Blind MethodExcitatory Amino Acid AntagonistsFemaleGlutamic AcidHumansLamotrigineMaleMiddle AgedOutcome Assessment, Health CareTriazines

DOI 10.1034/j.1600-0404.2003.00111.x

PMID 12807386

View source →